Fox News’s GOP debate last month generated blockbuster ratings — 24 million viewers saw Donald Trump and the other top Republican presidential contenders mix it up, making it the most-watched non-sports cable show ever. Now Fox News rival CNN is poised to cash in on that success.
The news network is asking advertisers to pay 40 times its usual rate, or as much as $200,000 for a 30-second commercial, during the second GOP debate, which it is scheduled to host on Sept. 16, according to Ad Age. CNN is also charging $50,000 to $60,000 for commercials airing that day in the earlier debate between second-tier candidates.
Ad Age says CNN isn’t expected to pull in quite the same level of viewership as Fox News did, but even if the next primetime debate fails to match the earlier numbers, it is still likely to be the most-watched debate CNN has ever aired. The network can thank Trump for that, just as it could thank another outspoken and unpredictable GOP phenomenon for helping to set its previous debate record: In 2008, almost 11 million viewers tuned in to the vice presidential debate between Joe Biden and — you betcha! — Sarah Palin.
If the Palin example holds, news networks aren’t going to be the only ones to benefit from the Trump surge. “Saturday Night Live” saw its viewership and buzz soar in 2008 as Tina Fey’s impersonation of Palin became a sensation in its own right. And when the former Alaska governor appeared on SNL in October 2008, the show drew its highest ratings in 14 years.
The new season of SNL starts Oct. 3, so it’s probably a safe bet that Lorne Michaels — and other executives at NBC, even after the network dumped Trump from The Celebrity Apprentice in the wake of his comments about Mexican immigrants — are rooting for Trump mania to keep going for another month, at least. In the meantime, NBC announced Tuesday that Trump will appear on “The Tonight Show” next week.
Top Reads from The Fiscal Times:
- Doctors to Trump: Deporting Illegal Immigrants Would Be Bad for U.S. Health
- How Much Does Our Social Safety Net Cost? $742 Billion a Year and Rising
- If Clinton Loses Her Security Clearance, Could She Still Be President?
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.